consolidated financial statements of the Company and its subsidiaries for the year ended 31st December 2019. In 2019, the Company achieved consolidated profits (attributable to equity holders of the parent) of
December 31, 2019. The year-on-year increase in finance costs was on a loan withdrawal to construction disbursement and purchasing medical equipment. Net profits The Company booked net profits of Baht 48.43
high progress rate of 37-38% depreciation change over same period of last year mainly due to the investment and launching of the new Excellence Center Building this year (2018). Profits According to the
542.9 1,020.0 510.1 100.0 Income tax expenses 153.6 116.4 32.0 155.3 (1.1) 408.6 478.5 (14.6) Profits before bad debts and doubtful accounts, and income tax expenses 1,370.5 1,347.5 1.7 1,004.4 36.4
542.9 1,020.0 510.1 100.0 Income tax expenses 153.6 116.4 32.0 155.3 (1.1) 408.6 478.5 (14.6) Profits before bad debts and doubtful accounts, and income tax expenses 1,370.5 1,347.5 1.7 1,004.4 36.4
management discussions and analysis regarding consolidated financial performance and position of the Company and subsidiaries (the “Group”) for the 3-month and 6-month period ended 30 June 2019 as follows
401.5 26.1 Other operating expenses 686.4 673.2 13.2 2.0 Bad debts, doubtful accounts and impairment loss 330.0 155.0 175.0 112.9 Income tax expenses 154.8 126.0 28.8 22.9 Profits before bad debts and
401.5 26.1 Other operating expenses 686.4 673.2 13.2 2.0 Bad debts, doubtful accounts and impairment loss 330.0 155.0 175.0 112.9 Income tax expenses 154.8 126.0 28.8 22.9 Profits before bad debts and
Quarter ended 31 March 2020 Page 5/20 Analysis of Operating Results In the year 2020, the operating results and the financial position of the company and its subsidiaries have been impacted, mainly from the
proportionate of house brand products in 1H19 was 64% increased from previous period resulted in higher gross profits margin. For the proportion of other income to total revenue, it’s slightly decreased compared